Teladoc Health (TDOC)
(Delayed Data from NYSE)
$9.04 USD
+0.36 (4.15%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $9.07 +0.03 (0.33%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$9.04 USD
+0.36 (4.15%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $9.07 +0.03 (0.33%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Zacks News
Pandemic Winners Turned Losers: Should You Still Buy?
by Derek Lewis
Once prosperous investments throughout the pandemic, the high-flying days for these stocks is well over in 2022.
Teladoc (TDOC) Plunges 40.3% Since Q1 Earnings Beat: Here's Why
by Zacks Equity Research
Teladoc Health's (TDOC) bet on mental health service BetterHelp is likely to generate lower yield this year.
Making Sense of Tech Sector Earnings After a Big Week of Results
by Sheraz Mian
Total Q1 earnings for the 'Big 5 Tech' players are down -8.4% from the same period last year on +11.4% higher revenues, with a 421 basis-points (bps) compression in net margins
The Zacks Analyst Blog Highlights Antero Resources, Arthur J. Gallagher, Teladoc Health, W. P. Carey and Weyerhaeuser
by Zacks Equity Research
Antero Resources, Arthur J. Gallagher, Teladoc Health, W. P. Carey and Weyerhaeuser have been included in this Analyst Blog.
Teladoc (TDOC) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of 14.55% and 0.63%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
5 Stocks to Buy Ahead of Q1 Earnings Results This Week
by Nalak Das
Five companies with a favorable Zacks Rank will report first-quarter earnings results this week. These are: WPC, WY, TDOC, AR and AJG.
Teladoc (TDOC) Stock Moves -1.35%: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $58.25, marking a -1.35% move from the previous day.
Teladoc (TDOC) Eyes Q1 Earnings Beat on Rising US Paid Members
by Zacks Equity Research
Teladoc Health's (TDOC) first-quarter 2022 results are likely to reflect improved subscription access fees revenues.
Teladoc (TDOC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Teladoc (TDOC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc (TDOC) Stock Moves -0.38%: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $65.81 in the latest trading session, marking a -0.38% move from the prior day.
Teladoc (TDOC) Stock Moves -1.29%: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $72.13, marking a -1.29% move from the previous day.
Why You Should Retain Teladoc Health (TDOC) Stock for Now
by Zacks Equity Research
Teladoc Health (TDOC) is focused on making strategic partnerships to boost user numbers.
Teladoc (TDOC) Up 12.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teladoc (TDOC) Stock Moves -0.94%: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $69.22, marking a -0.94% move from the previous day.
Teladoc Health's (TDOC) Virtual Care Model to Aid Companies
by Zacks Equity Research
Teladoc Health's (TDOC) first industry-standard model to help employers improve their package of telehealth services.
Teladoc (TDOC) Stock Moves -0.24%: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $63.55, marking a -0.24% move from the previous day.
Teladoc Health (TDOC) Tumbling: Is it Healthy for Your Portfolio?
by Zacks Equity Research
For this year, Teladoc Health (TDOC) projects total visits in the band of 18.5-20 million, indicating a rise from the 2021 level of 15.4 million.
Stock Market News for Mar 1, 2022
by Zacks Equity Research
U.S. stocks market closed mixed on Monday, the last trading day of February.
Teladoc Health (TDOC), Amazon Tie Up to Advance Virtual Care
by Zacks Equity Research
Teladoc Health (TDOC) collaborates with Amazon so that customers can avail quick and effective virtual care medical services via their Alexa-activated intelligent speakers.
Teladoc (TDOC) Q4 Loss Narrows on Higher Visits, Memberships
by Zacks Equity Research
Teladoc (TDOC) projects 2022 total visits in the band of 18.5-20 million, indicating an uptick from the 2021 level of 15.4 million.
Teladoc (TDOC) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of 88.14% and 1.09%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Teladoc Health, Albireo Pharma and The Joint Corp
by Zacks Equity Research
Teladoc Health, Albireo Pharma and The Joint Corp are included in this blog.
Teladoc (TDOC) Unveils Solution to Ease Whole-Person Care
by Zacks Equity Research
Teladoc Health (TDOC) launches Chronic Care Complete for extending a comprehensive suite of chronic condition management services for serving the whole-person health needs of eligible members.
Is a Surprise Coming for Teladoc (TDOC) This Earnings Season?
by Zacks Equity Research
Teladoc (TDOC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for Teladoc's (TDOC) Q4 Earnings?
by Zacks Equity Research
Teladoc Health's (TDOC) Q4 results are expected to gain from high sales and visits volume.